{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:25:18Z","timestamp":1790630718937,"version":"4.1.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T00:00:00Z","timestamp":1415836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T00:00:00Z","timestamp":1415836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/ncomms6418","type":"journal-article","created":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T06:18:31Z","timestamp":1415859511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":130,"title":["Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation"],"prefix":"10.1038","volume":"5","author":[{"given":"Kyung-Hyun","family":"Park-Min","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisha","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Joon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Giannopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Yarilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"van der Meulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baohong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Smithers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Witherington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul P.","family":"Tak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rab K.","family":"Prinjha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel B","family":"Ivashkiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,13]]},"reference":[{"key":"BFncomms6418_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","volume":"7","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292\u2013304 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"BFncomms6418_CR2","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1210\/er.2007-0038","volume":"29","author":"J Lorenzo","year":"2008","unstructured":"Lorenzo, J., Horowitz, M. & Choi, Y. Osteoimmunology: interactions of the bone and immune system. Endocr. Rev. 29, 403\u2013440 (2008).","journal-title":"Endocr. Rev."},{"key":"BFncomms6418_CR3","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. New Engl. J. Med. 365, 2205\u20132219 (2011).","journal-title":"New Engl. J. Med."},{"key":"BFncomms6418_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev.pathmechdis.3.121806.151431","volume":"3","author":"DV Novack","year":"2008","unstructured":"Novack, D. V. & Teitelbaum, S. L. The osteoclast: friend or foe? Annu. Rev. Pathol. 3, 457\u2013484 (2008).","journal-title":"Annu. Rev. Pathol."},{"key":"BFncomms6418_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher, K. N., Guise, T. A. & McCauley, L. K. Cancer to bone: a fatal attraction. Nat. Rev. Cancer 11, 411\u2013425 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms6418_CR6","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/jbmr.464","volume":"26","author":"T Yasui","year":"2011","unstructured":"Yasui, T. et al. Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1. J. Bone Miner. Res. 26, 2665\u20132671 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"BFncomms6418_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1749-6632.2011.06245.x","volume":"1240","author":"T Yasui","year":"2011","unstructured":"Yasui, T., Hirose, J., Aburatani, H. & Tanaka, S. Epigenetic regulation of osteoclast differentiation. Ann. N. Y. Acad. Sci. 1240, 7\u201313 (2011).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"BFncomms6418_CR8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature05918","volume":"447","author":"W Reik","year":"2007","unstructured":"Reik, W. Stability and flexibility of epigenetic gene regulation in mammalian development. Nature 447, 425\u2013432 (2007).","journal-title":"Nature"},{"key":"BFncomms6418_CR9","unstructured":"Allis C. D., Jenuwein T., Reinberg D. (eds)Epigentics Cold Spring Harbor Laboratory Press (2007)."},{"key":"BFncomms6418_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrg2752","volume":"11","author":"R Margueron","year":"2010","unstructured":"Margueron, R. & Reinberg, D. Chromatin structure and the inheritance of epigenetic information. Nat. Rev. Genet. 11, 285\u2013296 (2010).","journal-title":"Nat. Rev. Genet."},{"key":"BFncomms6418_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson, M. A. & Kouzarides, T. Cancer epigenetics: from mechanism to therapy. Cell 150, 12\u201327 (2012).","journal-title":"Cell"},{"key":"BFncomms6418_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nrd3674","volume":"11","author":"CH Arrowsmith","year":"2012","unstructured":"Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K. & Schapira, M. Epigenetic protein families: a new frontier for drug discovery. Nature reviews. Drug Discov. 11, 384\u2013400 (2012).","journal-title":"Drug Discov."},{"key":"BFncomms6418_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrc3256","volume":"12","author":"AC Belkina","year":"2012","unstructured":"Belkina, A. C. & Denis, G. V. BET domain co-regulators in obesity, inflammation and cancer. Nat. Rev. Cancer 12, 465\u2013477 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"BFncomms6418_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nature09589","volume":"468","author":"E Nicodeme","year":"2010","unstructured":"Nicodeme, E. et al. Suppression of inflammation by a synthetic histone mimic. Nature 468, 1119\u20131123 (2010).","journal-title":"Nature"},{"key":"BFncomms6418_CR15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature10509","volume":"478","author":"MA Dawson","year":"2010","unstructured":"Dawson, M. A. et al. Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478, 529\u2013533 (2010).","journal-title":"Nature"},{"key":"BFncomms6418_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.tips.2011.12.002","volume":"33","author":"RK Prinjha","year":"2012","unstructured":"Prinjha, R. K., Witherington, J. & Lee, K. Place your BETs: the therapeutic potential of bromodomains. Trends Pharmacol. Sci. 33, 146\u2013153 (2012).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFncomms6418_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067\u20131073 (2010).","journal-title":"Nature"},{"key":"BFncomms6418_CR18","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nature10334","volume":"478","author":"J Zuber","year":"2011","unstructured":"Zuber, J. et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478, 524\u2013528 (2011).","journal-title":"Nature"},{"key":"BFncomms6418_CR19","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nature13229","volume":"510","author":"IA Asangani","year":"2014","unstructured":"Asangani, I. A. et al. Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer. Nature 510, 278\u2013282 (2014).","journal-title":"Nature"},{"issue":"36","key":"BFncomms6418_CR20","doi-asserted-by":"publisher","first-page":"14532","DOI":"10.1073\/pnas.1212264109","volume":"109","author":"H. S. Bandukwala","year":"2012","unstructured":"Bandukwala, H. S. et al. Selective inhibition of CD4+ T-cell cytokine production and autoimmunity by BET protein and c-Myc inhibitors. Proc. Natl Acad. Sci. USA 109, 14532\u201314537.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"BFncomms6418_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00774-009-0148-5","volume":"28","author":"H Sasaki","year":"2010","unstructured":"Sasaki, H. et al. Effects of combination treatment with alendronate and vitamin K(2) on bone mineral density and strength in ovariectomized mice. J. Bone Miner. Metab. 28, 403\u2013409 (2010).","journal-title":"J. Bone Miner. Metab."},{"key":"BFncomms6418_CR22","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.4065\/83.9.1032","volume":"83","author":"MT Drake","year":"2008","unstructured":"Drake, M. T., Clarke, B. L. & Khosla, S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin. Proc. 83, 1032\u20131045 (2008).","journal-title":"Mayo Clin. Proc."},{"key":"BFncomms6418_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.molmed.2003.11.004","volume":"10","author":"HJ Ditzel","year":"2004","unstructured":"Ditzel, H. J. The K\/BxN mouse: a model of human inflammatory arthritis. Trends Mol. Med. 10, 40\u201345 (2004).","journal-title":"Trends Mol. Med."},{"key":"BFncomms6418_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1084\/jem.20020439","volume":"196","author":"H Ji","year":"2002","unstructured":"Ji, H. et al. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J. Exp. Med. 196, 77\u201385 (2002).","journal-title":"J. Exp. Med."},{"key":"BFncomms6418_CR25","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.4049\/jimmunol.167.3.1601","volume":"167","author":"BT Wipke","year":"2001","unstructured":"Wipke, B. T. & Allen, P. M. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 167, 1601\u20131608 (2001).","journal-title":"J. Immunol."},{"key":"BFncomms6418_CR26","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.bone.2012.08.113","volume":"51","author":"JF Charles","year":"2012","unstructured":"Charles, J. F. et al. The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption. Bone 51, 902\u2013912 (2012).","journal-title":"Bone"},{"key":"BFncomms6418_CR27","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1600-065X.2009.00821.x","volume":"231","author":"T Negishi-Koga","year":"2009","unstructured":"Negishi-Koga, T. & Takayanagi, H. Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation. Immunol. Rev. 231, 241\u2013256 (2009).","journal-title":"Immunol. Rev."},{"key":"BFncomms6418_CR28","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889\u2013901 (2002).","journal-title":"Dev. Cell"},{"key":"BFncomms6418_CR29","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.1172\/JCI35711","volume":"118","author":"AO Aliprantis","year":"2008","unstructured":"Aliprantis, A. O. et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J. Clin. Invest. 118, 3775\u20133789 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6418_CR30","doi-asserted-by":"publisher","first-page":"7063","DOI":"10.1158\/0008-5472.CAN-09-4291","volume":"70","author":"L Endo-Munoz","year":"2010","unstructured":"Endo-Munoz, L. et al. Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases. Cancer Res. 70, 7063\u20137072 (2010).","journal-title":"Cancer Res."},{"key":"BFncomms6418_CR31","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1084\/jem.20051150","volume":"202","author":"M Asagiri","year":"2005","unstructured":"Asagiri, M. et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202, 1261\u20131269 (2005).","journal-title":"J. Exp. Med."},{"key":"BFncomms6418_CR32","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1073\/pnas.0912779107","volume":"107","author":"K Nishikawa","year":"2010","unstructured":"Nishikawa, K. et al. Blimp1-mediated repression of negative regulators is required for osteoclast differentiation. Proc. Natl Acad. Sci. USA 107, 3117\u20133122 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6418_CR33","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1084\/jem.20091957","volume":"207","author":"Y Miyauchi","year":"2011","unstructured":"Miyauchi, Y. et al. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis. J. Exp. Med. 207, 751\u2013762 (2011).","journal-title":"J. Exp. Med."},{"key":"BFncomms6418_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/ar3379","volume":"13","author":"B Zhao","year":"2011","unstructured":"Zhao, B. & Ivashkiv, L. B. Negative regulation of osteoclastogenesis and bone resorption by cytokines and transcriptional repressors. Arthritis Res. Ther. 13, 234 (2011).","journal-title":"Arthritis Res. Ther."},{"key":"BFncomms6418_CR35","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904\u2013917 (2011).","journal-title":"Cell"},{"key":"BFncomms6418_CR36","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1359\/jbmr.2002.17.5.763","volume":"17","author":"R Battaglino","year":"2002","unstructured":"Battaglino, R. et al. c-myc is required for osteoclast differentiation. J. Bone. Miner. Res. 17, 763\u2013773 (2002).","journal-title":"J. Bone. Miner. Res."},{"key":"BFncomms6418_CR37","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1002\/jbmr.1976","volume":"28","author":"Y Indo","year":"2013","unstructured":"Indo, Y. et al. Metabolic regulation of osteoclast differentiation and function. J. Bone. Miner. Res. 28, 2392\u20132399 (2013).","journal-title":"J. Bone. Miner. Res."},{"key":"BFncomms6418_CR38","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.exphem.2006.06.019","volume":"34","author":"MJ Huang","year":"2006","unstructured":"Huang, M. J., Cheng, Y. C., Liu, C. R., Lin, S. & Liu, H. E. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. Exp. Hematol. 34, 1480\u20131489 (2006).","journal-title":"Exp. Hematol."},{"key":"BFncomms6418_CR39","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1073\/pnas.1010030108","volume":"108","author":"A Yarilina","year":"2011","unstructured":"Yarilina, A., Xu, K., Chen, J. & Ivashkiv, L. B. TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages. Proc. Natl Acad. Sci. USA 108, 1573\u20131578 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms6418_CR40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/ar2110","volume":"9","author":"G Schett","year":"2007","unstructured":"Schett, G. Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Res. Ther. 9, 203 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"BFncomms6418_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1749-6632.2011.06217.x","volume":"1237","author":"LB Ivashkiv","year":"2011","unstructured":"Ivashkiv, L. B., Zhao, B., Park-Min, K. H. & Takami, M. Feedback inhibition of osteoclastogenesis during inflammation by IL-10, M-CSF receptor shedding, and induction of IRF8. Ann. N.Y. Acad. Sci. 1237, 88\u201394 (2011).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BFncomms6418_CR42","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-pathol-011811-132438","volume":"7","author":"CA French","year":"2012","unstructured":"French, C. A. Pathogenesis of NUT midline carcinoma. Annu. Rev. Pathol. 7, 247\u2013265 (2012).","journal-title":"Annu. Rev. Pathol."},{"key":"BFncomms6418_CR43","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1038\/ncomms4511","volume":"5","author":"F Lamoureux","year":"2014","unstructured":"Lamoureux, F. et al. Selective inhibition of BET bromodomain epigenetic signalling interferes with the bone-associated tumour vicious cycle. Nat. Commun. 5, 3511 (2014).","journal-title":"Nat. Commun."},{"key":"BFncomms6418_CR44","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jbspin.2005.10.019","volume":"73","author":"V Breuil","year":"2006","unstructured":"Breuil, V. & Euller-Ziegler, L. Bisphosphonate therapy in rheumatoid arthritis. Joint Bone Spine 73, 349\u2013354 (2006).","journal-title":"Joint Bone Spine"},{"key":"BFncomms6418_CR45","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein, M. L. et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J. Bone Miner. Res. 25, 1468\u20131486 (2010).","journal-title":"J. Bone Miner. Res."},{"key":"BFncomms6418_CR46","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jbmr.1739","volume":"28","author":"KH Park-Min","year":"2013","unstructured":"Park-Min, K. H. et al. Negative regulation of osteoclast precursor differentiation by CD11b and beta2 integrin-B-cell lymphoma 6 signaling. J. Bone Miner. Res. 28, 135\u2013149 (2013).","journal-title":"J. Bone Miner. Res."},{"key":"BFncomms6418_CR47","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S1074-7613(00)80045-X","volume":"10","author":"AS Korganow","year":"1999","unstructured":"Korganow, A. S. et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 10, 451\u2013461 (1999).","journal-title":"Immunity"},{"key":"BFncomms6418_CR48","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1172\/JCI26132","volume":"115","author":"H Kitaura","year":"2005","unstructured":"Kitaura, H. et al. M-CSF mediates TNF-induced inflammatory osteolysis. J. Clin. Invest. 115, 3418\u20133427 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFncomms6418_CR49","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt, A. M. et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595\u2013610 (1987).","journal-title":"J. Bone Miner. Res."},{"key":"BFncomms6418_CR50","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jbmr.2082","volume":"29","author":"KM Melville","year":"2014","unstructured":"Melville, K. M. et al. Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength. J. Bone Miner. Res. 29, 370\u2013379 (2014).","journal-title":"J. Bone Miner. Res."},{"key":"BFncomms6418_CR51","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1016\/j.bmcl.2012.02.041","volume":"22","author":"J Seal","year":"2012","unstructured":"Seal, J. et al. Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A). Bio-org. Med. Chem. Lett. 22, 2968\u20132972 (2012).","journal-title":"Bio-org. Med. Chem. Lett."},{"key":"BFncomms6418_CR52","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1016\/j.bmcl.2012.01.125","volume":"22","author":"O Mirguet","year":"2012","unstructured":"Mirguet, O. et al. From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151. Bio-org. Med. Chem. Lett. 22, 2963\u20132967 (2012).","journal-title":"Bio-org. Med. Chem. Lett."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms6418.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms6418","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms6418.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T21:38:14Z","timestamp":1672954694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms6418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,13]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,23]]}},"alternative-id":["BFncomms6418"],"URL":"https:\/\/doi.org\/10.1038\/ncomms6418","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,13]]},"assertion":[{"value":"28 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.-H.P.-M., E.L., M.J.L., S.H.P., E.G., A.Y., M.M., B.Z. and L.B.I. declare no competing financial interests. N.S., K.L., J.W., P.P.T and R.K.P. are current or former employees of Glaxo Smith Kline and hence hold shares. GSK is testing BET Bromodomain inhibitors in clinical trials.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5418"}}